CLINICAL_TRIALS
trial_result
· 2016-03-03
Clinical Trial Update: A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects [Phase 3]
Summary
Phase 3 trial update assessing long-term safety of mepolizumab in asthmatic subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-03-03